OPKO Health announces landmark study showing 4Kscore® test is predictor of prostate cancer
OPKO Health announced data from a landmark study of the 4Kscore® test entitled, “Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men” were published in European Urology. March 16, 2018